Format

Send to

Choose Destination
Nat Rev Neurol. 2014 Sep;10(9):537-44. doi: 10.1038/nrneurol.2014.138. Epub 2014 Jul 29.

Guillain-Barré and Miller Fisher syndromes--new diagnostic classification.

Author information

1
Department of Neurology, Gloucestershire Royal Hospital, Great Western Road, Gloucester GL1 3NN, UK.
2
Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio, Via dei Vestini 31, Chieti 66013, Italy.
3
Departments of Medicine and Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Unit 09-01, Centre for Translational Medicine, 14 Medical Drive, Singapore 117599, Singapore.

Erratum in

  • Nat Rev Neurol. 2014 Nov;10(11):612.

Abstract

Guillain-Barré syndrome (GBS) and its variant, Miller Fisher syndrome (MFS), exist as several clinical subtypes with different neurological features and presentations. Although the typical clinical features of GBS and MFS are well recognized, current classification systems do not comprehensively describe the full spectrum of either syndrome. In this Perspectives article, GBS and MFS are classified on the basis of current understanding of the common pathophysiological profiles of each disease phenotype. GBS is subclassified into classic and localized forms (for example, pharyngeal-cervical-brachial weakness and bifacial weakness with paraesthesias), and MFS is divided into incomplete (for example, acute ophthalmoparesis, acute ataxic neuropathy) and CNS subtypes (Bickerstaff brainstem encephalitis). Diagnostic criteria based on clinical characteristics are suggested for each condition. We believe this approach to be more inclusive than existing systems, and argue that it could facilitate early clinical diagnosis and initiation of appropriate immunotherapy.

PMID:
25072194
DOI:
10.1038/nrneurol.2014.138
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center